State Key Laboratory of Experimental Hematology (SKLEH)


State Key Laboratory of Experimental Hematology (SKLEH), funded by the State Planning Commission and established in 1988, became operational in 1991. The lab is affiliated with Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College. Leveraging the synergies of basic science and clinical researches, SKLEH focuses on the research and treatment for hematological diseases in China. Taking hematopoietic stem cell biology as the main entry point with particular emphasis on pathogenesis of hematologic malignancies, the lab looks for normal and pathological hematopoietic stem cells and molecular targets for intervention in morbid hematopoietic microenvironment. The primary mission of SKLEH is to lead cutting edge researches and treatment practice in the field of hematology and to provide scientific basis of new clinical treatment strategies for various hematological disorders.

SKLEH has about 70 full-time staff members, among whom are recipients of numerous prestigious awards from China and aboard, including a member of French National Academy of Sciences and National Academy of Medical Sciences, a receiver of French Legion of Honor, 3 recipients of the National Science Fund for Outstanding Youth, 6 from the list of young and middle-aged with distinguished contributions selected by the Ministry of Health, and 1 from Top Innovation Leading Talents of Tianjin, forming an innovation group of the National Natural Science Foundation, a key-area innovation team of Ministry of Science and Technology, an innovation team of Ministry of Education, and 3 innovation teams of Chinese Academy of Medical Sciences.

SKLEH faculty members served as chairman, director-designate, vice chairman or council members for various professional committees of 53 international academic organizations, national primary and secondary scholarly associations, or working as editor-in-chief, deputy editor, or in editorial board for 28 international and domestic academic journals, such as deputy editor of the journalExperimental HematologyandInternational Journal of Hematology; and editors for more than ten acclaimed international journals, includingBloodandLeukemia, in the field of hematology; editor, deputy editor and editorial board of domestic core journals such asChinese Journal of Hematology.

In the past five years, SKLEH has undertaken a total of 234 various research projects, including 28 projects from the Ministry of Science and Technology, 76 projects from the National Natural Science Foundation, and 130 from other ministries and local governments. SKLEH also published 668 papers, of which nearly 300 papers were published in SCI, includingNatuer, Nat Genetics, Blood, Leukemia, Cell Researchand others, winning the National Science and Technology Progress Award, and 11 provincial science and technology awards. In a course of 5 years, SKLEH provides educational programs that produce 62 graduate and 121 doctoral students.

SKLEH, covering an area of 7400 square meters, has five major technology-sharing platforms that fully demonstrate the functions of a state key laboratory in public support and international scholarly communication and exchanges.